Pre-Tax Profit Margin: Earnings before taxes as a portion of total revenue. Calculated as: Pre-Tax Income / Total Revenues
Protalix BioTherapeutics, Inc. (PLX) had Pre-Tax Profit Margin of 21.08% for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$21.93M |
|
$3.96M |
|
$7.88M |
|
$14.05M |
|
$17.88M |
|
$4.05M |
|
$0.57M |
|
$4.62M |
|
$4.62M |
|
$3.96M |
|
$3.96M |
|
$3.96M |
|
$3.96M |
|
$4.05M |
|
$4.47M |
|
80.46M |
|
83.59M |
|
$0.05 |
|
$0.05 |
|
| Balance Sheet Financials | |
$98.87M |
|
$5.77M |
|
$19.37M |
|
$118.24M |
|
$30.23M |
|
-- |
|
$7.46M |
|
$37.69M |
|
$80.55M |
|
$80.55M |
|
$80.55M |
|
82.49M |
|
| Cash Flow Statement Financials | |
$15.53M |
|
$-13.22M |
|
$4.73M |
|
$14.68M |
|
$22.04M |
|
$7.36M |
|
$1.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.27 |
|
-- |
|
-- |
|
-- |
|
-- |
|
64.08% |
|
18.46% |
|
18.46% |
|
-- |
|
|
Pre-Tax Profit Margin |
21.08% |
18.07% |
|
$13.44M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
0.23 |
|
1.58 |
|
57.11 |
|
4.92% |
|
4.92% |
|
3.35% |
|
4.92% |
|
$0.98 |
|
$0.16 |
|
$0.19 |
|